SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-022353
Filing Date
2020-05-07
Accepted
2020-05-07 07:03:35
Documents
3
Period of Report
2020-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ortx-8k_20200507.htm 8-K 36780
2 EX-99.1 ortx-ex991_6.htm EX-99.1 99161
3 GRAPHIC gnysncqlvlpz000001.jpg GRAPHIC 16068
  Complete submission text file 0001564590-20-022353.txt   159368
Mailing Address 108 CANNON STREET LONDON X0 EC4N 6EU
Business Address 108 CANNON STREET LONDON X0 EC4N 6EU 011-44-0-203-3846700
Orchard Therapeutics plc (Filer) CIK: 0001748907 (see all company filings)

IRS No.: 000000000
Type: 8-K | Act: 34 | File No.: 001-38722 | Film No.: 20854517
SIC: 2836 Biological Products, (No Diagnostic Substances)